OpenAI launches GPT-Rosalind, an advanced AI model designed to accelerate drug discovery and genomics research.

3 Key Points

GPT-Rosalind is a frontier reasoning model built specifically for life sciences applications
The model is designed to accelerate drug discovery, genomics analysis, and protein reasoning workflows
The tool aims to enhance scientific research processes through advanced AI capabilities

Summaries like this, in your inbox every morning.

For example, today's edition would include:

DataAgent launches with $10M to auto-fix Kubernetes faultsSiliconANGLE AI · 1h ago
SK Hynix custom HBM boosts inference up to 5.15xDIGITIMES Asia · 1h ago
Nvidia Earnings: Boring by Design, Avoiding a Consolidated WorldStratechery (Ben Thompson) · 1h ago

AI-summarized, only the topics you pick — one digest a day via Email, Slack, or Discord.

Free · takes 30 seconds · unsubscribe anytimeWhat is AIToday? →

Ask AI anything about this article. Q&As are published on this page for other readers too.

Israeli startup DataAgent Ltd

SK Hynix presented a custom HBM concept at SEMICON Taiwan 2026, where compute functions are placed in the base…

Taoyuan is positioning itself as a northern hub for AI data centers (AIDC), citing the Tatan area and an LNG c…

The U.S. Department of Defense announced on August 31 that it has deployed ChatGPT Mil, a customized version o…

Nvidia reported earnings that were both remarkable and boring, reflecting its focus on avoiding a consolidated…

Anthropic has agreed to a $35bn cloud-computing contract with Lambda, a Nvidia-backed cloud provider